The inv(16) is one of the most frequent chromosomal translocations associat
ed with acute myeloid leukemia (AML). The inv(16) fusion protein acts by do
minantly interfering with AML-1/core binding factor beta-dependent transcri
ptional regulation. Here we demonstrate that the inv(16) fusion protein coo
perates with AML-1B to repress transcription. This cooperativity requires t
he ability of the translocation fusion protein to bind to AML-1B. Mutationa
l analysis and cell fractionation experiments indicated that the inv(16) fu
sion protein acts in the nucleus and that repression occurs when the comple
x is bound to DNA. We also found that the inv(16) fusion protein binds to A
ML-1B when it is associated with the mSin3A corepressor. An AML-1B mutant t
hat fails to bind mSin3A was impaired in cooperative repression, suggesting
that the inv(16) fusion protein acts through mSin3 and possibly other core
pressors. finally, we demonstrate that the C-terminal portion of the inv(16
) fusion protein contains a repression domain, suggesting a molecular mecha
nism for AML-1-mediated repression.